Omicron Booster Efficacy: Why Experts Believe They Will Work

[ad_1]
A study published Sept. 16 in the New England Journal of Medicine (NEJM) makes a strong case for an Omicron-based COVID-19 booster shot.
But first, a caveat: There are no data available yet demonstrating the effectiveness of the new Omicron booster authorized on Aug. 31, which protects against BA.4 and BA.5. The new study, conducted by Moderna, involves the company’s first combined vaccine that never came to market; it targets both the original SARS-CoV-2 virus and an earlier version of the Omicron variant, BA.1. It’s data that the U.S. Food and Drug Administration (FDA) and U.S. Centers for Disease Control and Prevention (CDC) relied on heavily in deciding whether to authorize the combination booster that targets the original virus and the latest Omicron variants, BA.4 and BA.5. Human studies involving the new authorized boosters from Moderna and Pfizer-BioNTech have just begun and won’t be completed for another few months.
The data provided by Moderna in the NEJM study are the best proxy we have right now for how well the new boosters work, and the results are promising. In the study, more than 800 volunteers received either a booster dose of Moderna’s original shot against SARS-CoV-2 or a booster dose of the bivalent booster against both the original and Omicron BA.1 strains. All people in the study had been vaccinated with the primary series of two Moderna doses and boosted once before beginning the study.
Read More: COVID-19 Boosters Help Keep People Out of the Hospital, Study Finds
About a month after their shot, people who received the bivalent booster showed higher levels of virus-fighting antibodies than people who got the original booster. The antibodies generated were also able to better bind to and neutralize not just the original and BA.1 viruses, but nearly all of the other known variants as well, including Alpha, Beta, Gamma, Delta, and Omicron BA.4 and BA.5.
Pfizer-BioNTech—which also made a bivalent BA.1 vaccine that didn’t come to market—reported similarly encouraging results of its bivalent BA.1 booster to the FDA’s vaccine expert committee last June, but has not yet published those results in a scientific journal. At the FDA meeting (at which Moderna had also presented its BA.1 bivalent data), Pfizer-BioNTech showed data from a study involving more than 300 people ages 55 and older who received the bivalent booster. People who got it generated significantly higher levels of antibodies against BA.1, as well as BA.4 and BA.5, compared to those receiving the original booster. The level of antibodies was lower against BA.4 and BA.5, however, than the level produced against BA.1. The study also showed that the side effects associated with the Omicron BA.1 bivalent vaccine were similar to those of the original vaccine.
As more people roll up their sleeves to get the new Omicron booster, data on how well the vaccine protects people not just from serious illness, but also from infection, will become clear. Researchers will also be looking at how long that protection lasts. The hope is that better matching the vaccine booster to the circulating strain will afford people more durable protection and lead to yearly, rather than more frequent, shots.
More Must-Read Stories From TIME
More Must-Read Stories From TIME
[ad_2]
Source link
Q&A: Could an Apple Watch change the ‘one-size-fits-all’ approach to AFib?

[ad_1]

Late last month, Northwestern University and Johns Hopkins University announced they had received about $37 million from the National Heart, Lung and Blood Institute to study a new approach to stroke prevention in patients with atrial fibrillation, an irregular heart rhythm.
The funds will support the Rhythm Evaluation for AntiCoagulaTion (REACT-AF) trial, a seven-year study that will provide some patients with an Apple Watch to monitor for AFib. They’ll be able to take blood thinners in response to a prolonged episode, while patients in the control group will receive the current standard of care, continuously taking the drug to reduce stroke risk.
Dr. Rod Passman, director of the Center for Arrhythmia Research at Northwestern’s Feinberg School of Medicine and principal investigator of the study, sat down with MobiHealthNews to explain the upcoming research and how consumer devices could improve patient care.
MobiHealthNews: Can you explain the study design and what you’re hoping to learn from this research?
Dr. Rod Passman: We’re looking at the major problem of the most common abnormal heart rhythm, which is atrial fibrillation. We know that people with atrial fibrillation, particularly those with other cardiovascular risk factors like high blood pressure, are at a substantially increased risk of stroke.
The current approach is to take a blood thinner. If you apply the criteria for being on a blood thinner to the U.S. population with atrial fibrillation, maybe 80-plus percent of patients who have atrial fibrillation would be on these anticoagulants for the rest of their lives. We sort of have a one-size-fits-all approach. We treat people who are continuously in the abnormal rhythm with the same daily blood thinner as we do the individual who has one episode a year, or who has no further episodes because they’ve had an ablation done, or they’re on a drug, or they’ve lost weight, or they’ve stopped drinking alcohol.
So, I think this one-size-fits-all approach doesn’t make a lot of sense in an era where we can monitor people to see whether they’re truly having episodes. So, the goal here was to evaluate a paradigm shift, right? Instead of looking at individuals at risk, can we look at periods of risk? Can we treat at-risk patients with a targeted approach to being on a blood thinner, where they take it only for a few weeks and only in response to a multi-hour episode of atrial fibrillation?
MHN: If this method of continuous monitoring is validated by the study, how do you think this would improve upon the current standard of care?
Passman: From our estimates, this approach may apply to maybe half the population with atrial fibrillation. And what this means is that we can reduce the exposure to these medications, which are very effective at reducing stroke risk but are also contributors to both major and minor bleeding.
So, if we can protect people against stroke and minimize the exposure to the risks of the blood thinners, then we can improve the lives of our patients. And this has other implications, right? Not only would this be protective against stroke and reduce bleeding risk, but this would also, we believe, improve their quality of life because many patients curtail their activities. They may not go mountain biking or skiing because of the risks of trauma.
We also believe that this would be a cost savings to the healthcare system because these blood thinners can be costly and the cost of bleeding on these blood thinners is a major expense. So, if you can buy a device at your local electronics store for a fraction of the cost, this could not only improve quality of life, but do so at a lower cost.
MHN: Why did you choose to use a consumer device, the Apple Watch, for the study, as opposed to a clinical monitoring system?
Passman: We did two pilot studies, one using implantable cardiac monitors, and one using pacemakers and defibrillators. Those devices are very accurate in detecting atrial fibrillation. The problem is, the cost of using an implantable monitor for this indication is not scalable to the tens of millions of people around the world who may benefit from this approach.
More importantly, these devices are not patient-facing, they’re physician-facing. As your doctor, I may get the data from your implantable monitor, and I may get it a day later. A consumer electronics device is much more scalable, and the patient gets alerted when they have an episode.
Those issues allow us to ultimately make this point-of-care. This will be like a diabetic who checks their blood sugar, knows how much insulin to take in response to a particular level and can do that task without ever having to call their doctor. If this is a positive study, we hope that stroke prevention and atrial fibrillation follow a similar path.
MHN: You’ve done other research and written about wearables and digital health technology for this type of monitoring. What do you think are some of the obstacles to using these kinds of tools more broadly within the healthcare system?
Passman: From a patient perspective, there are still costs involved that may create barriers for some individuals. I do think that the healthcare system is not necessarily well-equipped to deal with the deluge of data that may be coming from these wearable devices that we may be asked to assess.
And I think in many cases, the technology is out there, but the pivotal trials showing that the use of this technology improves lives is still lacking. So, we believe that this study is a major step in critically evaluating a consumer-grade electronics device to show how we can leverage this technology that you can buy at Best Buy to save your life, reduce cost, and improve both how long you live and how well you live.
MHN: Some digital health technologies have clinical evidence behind them, but a lot of them do not. From a clinician’s perspective, does that make it difficult to recommend these tools to patients?
Passman: In the case of Apple, they and many companies have gone through rigorous evaluation of the technology to assess the accuracy. So, in many cases, these devices do perform in the way that we want them to. The Apple Heart Study and the Fitbit study are massive trials that I think did a really good job of evaluating can these devices do what they’re supposed to be doing.
But how we integrate this into care, and how we prove that giving patients these powerful tools impacts their journey through the healthcare system, those kinds of studies are lacking. I think that, in many cases, this technology has appeared faster than our ability to figure out how to integrate this into care.
The example I give is, in the traditional healthcare system, a doctor orders tests and then we get the results and we discuss with the patient. Digital health allows patients to give us the results of a test that we didn’t order. And we need to prove, as I suspect that we will, that that allows us to diagnose disease earlier to keep people at home and to manage their disease remotely.
But that will challenge the traditional healthcare system, where people come to an office appointment when they’re feeling well or an emergency department when they’re feeling poorly. We need to create the systems that allow us to take this information and manage patients remotely, and make sure that we are allowing this technology to keep patients away from the healthcare system.
[ad_2]
Source link
Period tracking app Flo releases anonymous mode and more digital health briefs

[ad_1]

Period tracking app Flo released its previously announced anonymous mode, which the company said will allow users to access the app without associating their name, email address and technical identifiers with their health data.
Flo partnered with security firm Cloudflare to build the new feature and released a white paper detailing its technical specifications. Anonymous mode has been localized into 20 languages, and it’s currently available for iOS users. Flo said Android support will be added in October.
“Women’s health information shouldn’t be a liability,” Cath Everett, VP of product and content at Flo, said in a statement. “Every day, our users turn to Flo to gain personal insights about their bodies. Now, more than ever, women deserve to access, track and gain insight into their personal health information without fearing government prosecution. We hope this milestone will set an example for the industry and inspire companies to raise the bar when it comes to privacy and security principles.”
Flo first announced plans to add an anonymous mode shortly after the Supreme Court’s Dobbs decision that overturned Roe v. Wade. Privacy experts raised concerns that the data contained in women’s health apps could be used to build a case against users in states where abortion is now illegal. Others have argued different types of data are more likely to point to illegal abortions.
Still, reports and studies have noted many popular period tracking apps have poor privacy and data sharing standards. The U.K.-based Organisation for the Review of Care and Health Apps found most popular apps share data with third parties, and many embed user consent information within the terms and conditions.
Brentwood, Tennessee-based LifePoint Health announced a partnership with Google Cloud to use its Healthcare Data Engine to aggregate and analyze patient information.
Google Cloud’s HDE pulls and organizes data from medical records, clinical trials and research data. The health system said using the tool will give providers a more holistic view of patients’ health data, along with offering analytics and artificial intelligence capabilities. LifePoint will also use HDE to build new digital health programs and care models as well as integrate third-party tools.
“LifePoint Health is fundamentally changing how healthcare is delivered at the community level,” Thomas Kurian, CEO of Google Cloud, said in a statement. “Bringing data together from hundreds of sources, and applying AI and machine learning to it will unlock the power of data to make real-time decisions — whether it is around resource utilization, identifying high-risk patients, reducing physician burnout, or other critical needs.”
The National Institutes of Health announced this week it will invest $130 million over four years, as long as the funds are available, to expand the use of artificial intelligence in biomedical and behavioral research.
The NIH Common Fund’s Bridge to Artificial Intelligence (Bridge2AI) program aims to build “flagship” datasets that are ethically sourced and trustworthy as well as determine best practices for the emerging technology. It will also produce data types that researchers can use in their work, like voice and other markers that could signal potential health problems.
Although AI use has been expanding in the life science and healthcare spaces, the NIH said its adoption has been slowed because biomedical and behavioral datasets are often incomplete and don’t contain information about data type or collection conditions. The agency notes this can lead to bias, which experts say can compound existing health inequities.
“Generating high-quality ethically sourced datasets is crucial for enabling the use of next-generation AI technologies that transform how we do research,” Dr. Lawrence A. Tabak, who is currently performing the duties of the director of NIH, said in a statement. “The solutions to long-standing challenges in human health are at our fingertips, and now is the time to connect researchers and AI technologies to tackle our most difficult research questions and ultimately help improve human health.”
[ad_2]
Source link
New and Noteworthy: What I Read This Week—Edition 194

[ad_1]

Research of the Week
Turns out that “depression as realism” is a complete myth.
Both step counts and step intensity affect mortality risk.
Time-restricted eating improves glucose homeostasis without affecting insulin sensitivity.
Sex differences in brain tumor treatment.
Diluting old plasma with younger plasma improves aging, possibly mediated by changes to the gut biome.
New Primal Kitchen Podcasts
Primal Kitchen Podcast: The Link Between Dairy Intolerance and Dairy Genes with Alexandre Family Farm Founders Blake and Stephanie
Primal Health Coach Radio: There is More to Fitness Than Cardio with Ashleigh VanHouten
Media, Schmedia
Authors of a bad red meat study are getting pressured to revisit their methods.
Ultraprocessed foods are still bad for you even when you control for nutrient content.
Interesting Blog Posts
Beta-hydroxybutyrate and cardiovascular health.
Social Notes
Everything Else
That red meat study is looking worse and worse.
COVID was here much earlier than 2020.
Low-level aerobic activity can counter some of the negative effects of bad sleep.
Things I’m Up to and Interested In
Interesting research: Did Neanderthals obtain significant amounts of carbohydrates from their animal foods?
Huge: The Cleveland Clinic now lists keto and IF as good options for reversing pre-diabetes.
Important new article: Is saturated fat just a bogeyman?
Simple but overlooked: CoQ10 fights fatigue.
Interesting paper: UFOs over Ukraine.
Question I’m Asking
How do you handle a night of bad sleep?
Recipe Corner
- Moo shu chicken.
- A fantastic Filipino grilled chicken dish.
Time Capsule
One year ago (Sep 11 – Sep 17)
- The Benefits of Pumpkin and Pumpkin Seeds—Why you should eat them.
- Yerba Mate: Miracle Tea or Just Another Caffeine Kick?—All about Yerba mate.
Comment of the Week
“Eat enough of that Nigerian stock and you probably won’t have to worry about Original Antigenic Sin (though I’d skip the new bivalent boosters anyway).”
-Maybe, Jesse, maybe.
(function($) {
$(“#dfolCEZ”).load(“https://www.marksdailyapple.com/wp-admin/admin-ajax.php?action=dfads_ajax_load_ads&groups=674&limit=1&orderby=random&order=ASC&container_id=&container_html=none&container_class=&ad_html=div&ad_class=&callback_function=&return_javascript=0&_block_id=dfolCEZ” );
})( jQuery );
The post New and Noteworthy: What I Read This Week—Edition 194 appeared first on Mark's Daily Apple.
[ad_2]
Source link
New Science Reveals the Best Way to Take a Pill

[ad_1]
Sept. 16, 2022 – I want to tell you a story about forgetfulness and haste, and how the combination of the two can lead to frightening consequences. A few years ago, I was lying in bed about to turn out the light when I realized I’d forgotten to take “my pill.”
Like some 161 million other American adults, I was then a consumer of a prescription medication. Being conscientious, I got up, retrieved said pill, and tossed it back. Being lazy, I didn’t bother to grab a glass of water to help the thing go down. Instead, I promptly returned to bed, threw a pillow over my head, and prepared for sleep.
Within seconds, I began to feel a burning sensation in my chest. After about a minute, that burn became a crippling pain. Not wanting to alarm my wife, I went into the living room, where I spent the next 30 minutes doubled over in agony. Was I having a heart attack? I phoned my sister, a hospitalist in Texas. She advised me to take myself to the emergency room to get checked out.
If only I’d known then about “Duke.” He could have told me how critical body posture is when people swallow pills.
Who’s Duke?
Duke is a computer representation of a 34-year-old, anatomically normal human male created by computer scientists at the IT’IS Foundation, a nonprofit group based in Switzerland that works on a variety of projects in health care technology. Using Duke, Rajat Mittal, PhD, a professor of medicine at the Johns Hopkins School of Medicine in Baltimore, created a computer model called “StomachSim” to explore the process of digestion.
Their research, published in the journal Physics of Fluids, turned up several surprising findings about the dynamics of swallowing pills – the most common way medication is used worldwide.
Mittal says he chose to study the stomach because the functions of most other organ systems, from the heart to the brain, have already attracted plenty of attention from scientists.
“As I was looking to initiate research in some new directions, the implications of stomach biomechanics on important conditions such as diabetes, obesity, and gastroparesis became apparent to me,” he says. “It was clear that bioengineering research in this arena lags other more ‘sexy’ areas such as cardiovascular flows by at least 20 years, and there seemed to be a great opportunity to do impactful work.”
Your Posture May Help a Pill Work Better
Several well-known things affect a pill’s ability to disperse its contents into the gut and be used by the body, such as the stomach’s contents (a heavy breakfast, a mix of liquids like juice, milk, and coffee) and the motion of the organ’s walls. But Mittal’s group learned that Duke’s posture also played a major role.
The researchers ran Duke through computer simulations in varying postures: upright, leaning right, leaning left, and leaning back, while keeping all the other parts of their analyses (like the things mentioned above) the same.
They found that posture determined as much as 83% of how quickly a pill disperses into the intestines. The most efficient position was leaning right. The least was leaning left, which prevented the pill from reaching the antrum, or bottom section of the stomach, and thus kept all but traces of the dissolved drug from entering the duodenum, where the stomach joins the small intestine. (Interestingly, Jews who observe Passover are advised to recline to the left during the meal as a symbol of freedom and leisure.)
That makes sense if you think about the stomach’s shape, which looks kind of like a bean, curving from the left to the right side of the body. Because of gravity, your position will change where the pill lands.
In the end, the researchers found that posture can be as significant a factor in how a pill dissolves as gastroparesis, a condition in which the stomach loses the ability to empty properly.
How This Could Help People
Among the groups most likely to benefit from such studies, Mittal says, are the elderly – who both take a lot of pills and are more prone to trouble swallowing because of age-related changes in their esophagus – and the bedridden, who can’t easily shift their posture. The findings may also lead to improvements in the ability to treat people with gastroparesis, a particular problem for people with diabetes.
Future studies with Duke and similar simulations will look at how the GI system digests proteins, carbohydrates, and fatty meals, Mittal says.
In the meantime, Mittal offers the following advice: “Standing or sitting upright after taking a pill is fine. If you have to take a pill lying down, stay on your back or on your right side. Avoid lying on your left side after taking a pill.”
As for what happened to me, any gastroenterologist reading this has figured out that my condition was not heart-related. Instead, I likely was having a bout of pill esophagitis, irritation that can result from medications that aggravate the mucosa of the food tube. Although painful, esophagitis isn’t life-threatening. After about an hour, the pain began to subside, and by the next morning I was fine, with only a faint ache in my chest to remind me of my earlier torment. (Researchers noted an increase in the condition early in the COVID-19 pandemic, linked to the antibiotic doxycycline.)
And, in the interest of accuracy, my pill problem began above the stomach. Nothing in the Hopkins research suggests that the alignment of the esophagus plays a role in how drugs disperse in the gut – unless, of course, it prevents those pills from reaching the stomach in the first place.
[ad_2]
Source link
Bodybuilder Regan Grimes Withdraws from the 2022 Mr. Olympia

[ad_1]
Regan Grimes will not participate in this year’s upcoming 2022 Mr. Olympia. On Sept. 15, 2022, the bodybuilder announced the decision during an episode of four-time Mr. Olympia Jay Cutler’s podcast, the Cutler Cast. Grimes will shift his focus to 2023 in a mission to build more mass.
[Related: How to Do Dips for Chest Size and Strength]
Grimes made the appearance on Cutler’s podcast alongside his coach Miloš Šarčev. The pair outlined Grimes’ upcoming strength training plans, maintaining that Grimes’ new goal is to add 15 pounds of muscle mass before returning to compete at the 2023 Olympia. Grimes finished in 15th place in each of the last two Mr. Olympia contests and would like to improve his results the next time he steps onto the Olympia stage. (Note: Šarčev also coaches Grimes’ fellow Men’s Open competitors Samson Dauda and Joe Mackey.)
“I want to really get in the top five, and I don’t think, right now, I’m just not there yet,” Grimes says. “So this year, we’ve decided to take it off and continue this rhythm of putting the tissue on, and we’ll hit a show next year and go to Olympia.”
Grimes says he weighs 295 pounds in the clip, but after consultation with Šarčev with the contest roughly four months away — the two agreed that Grimes’ progress wasn’t where they wanted at this point in the lead-up process.
[Related: How to Do the Reverse Crunch for Strong, Well-Developed Abs]
Over the past few years, Grimes has been a consistent fixture in the competitive bodybuilding scene.
According to NPC News Online, among other notable appearances aside from the last two Olympias, Grimes won the 2018 New York Pro as a Classic Physique competitor. He also took first place in the Men’s Open division at the 2020 Romania Muscle Fest Pro. With more time on his plate instead of focusing on any pending contests, Grimes says stepping away from the Olympia will allow him more flexibility to improve his physique for the future.
Meanwhile, Šarčev was candid, saying he doesn’t believe Grimes had the appropriate size to overcome established Men’s Open stars like Mamdouh “Big Ramy” Ellsbiay, Brandon Curry, Nick Walker, Hunter Labrada, and Hadi Choopan.
“It’s still a muscle contest — it doesn’t matter what we say,” Sarcev says. “When you stand next to ‘Big Ramy,’ you have to have size. And if he doesn’t have it, he would be outclassed.”
Cutler echoed a similar sentiment about Big Ramy and any potential challengers.
“A month ago, I said okay, people may challenge [Big Ramy]. But now, I can’t see him losing being in the shape he is in.”
[Related: How to Do the Triceps Kickback for Arm Size]
Grimes earned an automatic qualification for the 2022 Mr. Olympia by winning the 2022 Cairo Pro. This past competitive year also saw respective seventh-place results at the 2022 Arnold Classic and 2022 Boston Pro.
At the time of this writing, Grimes has not clarified when he would compete next as he resets his sights on the 2023 Olympia. In the next instance that Grimes is seen on a stage, his physique could look dramatically different.
Featured image: @regangrimes on Instagram
[ad_2]
Source link
With Polio’s Return, Here’s What Back to Schoolers Need to Know

[ad_1]
Friday, September 16, 2022 (Kaiser News) — Before polio vaccines became available in the 1950s, people wary of the disabling disease were afraid to allow their children outside, let alone go to school. As polio appears again decades after it was considered eliminated in the U.S., Americans unfamiliar with the dreaded disease need a primer on protecting themselves and their young children — many of whom are emerging from the trauma of the covid-19 pandemic.
What is poliomyelitis?
Polio is short for “poliomyelitis,” a neurological disease caused by a poliovirus infection. Of the three types of wild poliovirus — serotypes 1, 2, and 3 — serotype 1 is the most virulent and the most likely to cause paralysis.
Most people infected with poliovirus don’t get sick and won’t have symptoms. About a quarter of those infected might experience mild symptoms like fatigue, fever, headache, neck stiffness, sore throat, nausea, vomiting, and abdominal pain. So, as with covid-19, people who don’t have symptoms can unknowingly spread it as they interact with others. But in up to 1 in 200 people with a poliovirus infection, the virus may attack the spinal cord and brain. When it infects the spinal cord, people may develop muscle weakness or paralysis, including of the legs, arm, or chest wall. Poliovirus may also infect the brain, leading to difficulty breathing or swallowing.
People can develop post-polio syndrome decades after infection. Symptoms may include muscle pain, weakness, and wasting.
People with poliomyelitis may remain wheelchair-bound or unable to breathe without the help of a ventilator for the rest of their lives.
How does polio spread?
The virus that causes polio spreads through the “oral-fecal route,” which means it enters the body through the mouth by way of the hands, water, food, or other items contaminated with poliovirus-containing feces. Rarely, poliovirus may spread through saliva and upper respiratory droplets. The virus then infects the throat and gastrointestinal tract, spreads to the blood, and invades the nervous system.
How do doctors diagnose polio?
Poliomyelitis is diagnosed through a combination of patient interviews, physical examinations, lab testing, and scans of the spinal cord or brain. Health care providers may send feces, throat swabs, spinal fluid, and other specimens for lab testing. But because polio has been vanishingly rare in the United States for decades, doctors may not consider the diagnosis for patients with symptoms. And tests for suspected polio must be sent to the Centers for Disease Control and Prevention, since even academic centers no longer perform the tests.
How can poliovirus transmission be prevented?
The CDC recommends that all children be vaccinated against polio at ages 2 months, 4 months, 6 to 18 months, and 4 to 6 years, for a total of four doses. All 50 states and the District of Columbia require that children attending day care or public school be immunized against polio, but some states allow medical, religious, or personal exemptions. The Vaccines for Children program provides polio vaccine free of charge for children who are eligible for Medicaid, uninsured, or underinsured, or who are American Indian or Alaska Native. Most people born in the United States after 1955 likely have been vaccinated for polio. But in some areas the vaccination rates are dangerously low, such as New York’s Rockland County, where it is 60%, and Yates County, where it is 54%, because so many families there claim religious exemptions.
There are two types of polio vaccine: killed, inactivated polio vaccine (IPV) and weakened, live, oral polio vaccine (OPV). IPV is an injectable vaccine. OPV may be given by drops in the mouth or on a sugar cube, so it’s easier to administer. Both vaccines are highly effective against paralytic poliomyelitis, but OPV appears to be more effective in preventing infection and transmission.
Both the wild poliovirus and the live, weakened OPV viruses can cause infection. Because IPV is a killed virus vaccine, it cannot infect or replicate, give rise to vaccine-derived poliovirus, or cause paralytic poliomyelitis disease. The weakened, OPV viruses can mutate and regain their ability to cause paralysis — what’s called vaccine-derived poliomyelitis.
Since 2000, only IPV has been given in the United States. Two doses of IPV are at least 90% effective and three doses of IPV are at least 99% effective in preventing paralytic poliomyelitis disease. The United States stopped using OPV due to a 1-in-2,000 risk of paralysis among unvaccinated persons receiving OPV. Some countries still use OPV.
Vaccination against polio began in 1955 in the United States. Cases of paralytic poliomyelitis disease plummeted from over 15,000 a year in the early 1950s to under 100 in the 1960s and then down to fewer than 10 in the 1970s. Today, poliovirus is most likely to spread where hygiene and sanitation are poor and vaccination rates are low.
Why is polio spreading again?
The World Health Organization declared North and South America polio-free as of 1994, but in June 2022, a young adult living in Rockland County, New York, was diagnosed with serotype 2 vaccine-derived poliovirus. The patient complained of fever, neck stiffness, and leg weakness. The patient had not traveled recently outside the country and was presumably infected in the United States. The CDC has since started to monitor wastewater for poliovirus. Poliovirus genetically linked to the Rockland County case has been detected in wastewater samples from Rockland, Orange, and Sullivan counties, demonstrating community spread as far back as May 2022. Unrelated vaccine-derived poliovirus has also been detected in New York City wastewater.
How do I know if I’ve been vaccinated against polio?
There is no national database of immunization records, but all 50 states and the District of Columbia have immunization information systems with records going as far back as the 1990s. Your state or territorial health department may also have records of your vaccinations. People immunized in Arizona, the District of Columbia, Louisiana, Maryland, Mississippi, North Dakota, and Washington can access their immunization records using the MyIR Mobile app, and those who got vaccines in Idaho, Minnesota, New Jersey, and Utah can do so using the Docket app.
You may also ask your parents, your childhood pediatrician, your current doctor or pharmacist, or the K-12 schools, colleges, or universities you attended if they have records of your vaccinations. Some employers, like health care systems, may also keep records of your vaccinations in their occupational health office.
There is no test to determine if you’re immune to polio.
Do I need a polio vaccine booster if I was fully vaccinated against polio as a child?
All children and unvaccinated adults should complete the CDC-recommended four-dose series of polio vaccinations. You do not need an IPV booster if you received OPV.
Adults who are immunocompromised, traveling to a country where poliovirus is circulating, or at increased risk for exposure to poliovirus on the job, such as some lab workers and health care workers, may get a one-time IPV booster.
How is polio treated?
People with mild poliovirus infection don’t require treatment. Symptoms usually go away on their own within a couple of days.
There is no cure for paralytic poliomyelitis. Treatment focuses on physical and occupational therapy to help patients adapt and regain function.
Why hasn’t poliovirus been eradicated?
Smallpox is the only human virus to have been declared eradicated to date. A disease may be eradicated if it infects only humans, if viral infection induces long-term immunity to reinfection, and if an effective vaccine or other preventive exists. The more infectious a virus, the more difficult it is to eradicate. Viruses that spread asymptomatically are also more difficult to eradicate.
In 1988, the World Health Assembly resolved to eradicate polio by 2000. Violent conflict, the spread of conspiracy theories, vaccine skepticism, inadequate funding and political will, and poor-quality vaccination efforts slowed progress toward eradication, but before the covid pandemic, the world had gotten very close to eradicating polio. During the pandemic, childhood immunizations, including polio vaccinations, dipped in the U.S. and around the world.
To eradicate polio, the world must eradicate all wild polioviruses and vaccine-derived polioviruses. Wild poliovirus serotypes 2 and 3 have been eradicated. Wild poliovirus serotype 1, the most virulent form, remains endemic only in Pakistan and Afghanistan, but vaccine-derived polioviruses continue to circulate in some countries in Africa and other parts of the world. A staged approach involving the use of OPV, then a combination of OPV and IPV, and then IPV alone would likely be needed to finally eradicate polio from the planet.
KHN (Kaiser Health News) is a national newsroom that produces in-depth journalism about health issues. Together with Policy Analysis and Polling, KHN is one of the three major operating programs at KFF (Kaiser Family Foundation). KFF is an endowed nonprofit organization providing information on health issues to the nation.
[ad_2]
Source link
Have a Delicious Weekend. | Cup of Jo

[ad_1]

What are you up to this weekend? My dad is visiting, and we’re going to our neighborhood block party. The boys are psyched for the bouncy house, and I like seeing what everyone brings to the potluck dinner. We’re going with either thumbprint cookies or fancified Rice Krispie treats. Hope you have a good one, and here are a few links from around the web…
Today’s the last day to enter to win our Cup of Jo NYC trip!
Everyone should wear absolutely huge sunglasses. “All fashion should make you say, ‘Hmm, seems stupid. I love it.’ Sunglasses most of all.” (NYMag)
Love the idea of taking long walks and just talking to yourself.
Oooh, the perfect sweater for a hair tuck.
A conversation about household inequity. Says Anne Helen Petersen: “I know so many cis-hetero couples where guys leave for eight hours to go golfing every weekend; eight hours to go to a friend’s house or to go to an actual football game, every weekend. That is a massive amount of time that seems inconceivable to a lot of women in those hetero partnerships. I think that men are like… Why would they want to change that? Why would they want to take that away? If all they have to do is just get in a fight every once in a while about it, that seems like a small price to pay for having all of that freedom.”
“Who cares what I wear to school drop off? Me.” Such a funny, playful piece. (NYTimes gift link)
This short film is making fetch happen — in Yiddish.
When it comes to eating disorders, brown girls don’t measure up. “I am a South Asian woman who suffers from eating disorders. My struggle with body dysmorphia began when I was told by my doctor, at six years old, that my BMI (body mass index) was too high, and I was put on the first of many diets that would come to define my life. Ever the overachiever and eager to please my concerned parents, I threw myself into controlling my weight… What I didn’t know at that time was that those numbers were reflective of white, Eurocentric standards that never should have been applied to me… Eating disorder behavior is so closely tied with whiteness and wealth, that for many — including many women of color — the depictions of it can be unintentionally aspirational.” (Elle)
The hair trend that millennial and boomers agree on. *raises hand*
Digging this sexy underwear.
“The faces that look back at us when we come out as queer.” What an amazing interactive article. (NYTimes gift link)
Plus, five reader comments:
Says Sarah on how to say goodbye at a party: “I practice the Midwestern goodbye. When sitting, slap your lap with both hands, say, ‘Welp!’, then stand up and head out the door.”
Says Tina on how to say goodbye at a party: “Ever do an Italian family goodbye? Endless hugs, kisses, questions about being hungry, being forced to take leftovers, getting sucked into having one last piece of/plate of… It’s endless! The best/worst is that we will likely see them TOMORROW!”
Says Ruth on how to say goodbye at a party: “My party vibe as a Jew is: ‘What party? We’re all living together in this tent in the desert full time. Why would you want to leave? Especially since Aunt Rachel’s cake is just coming off the fire!’ I cannot leave a party. Please don’t make me.”
Says Nigerian Girl on 10 single moms by choice share their experiences: “I just listened to the latest episode of the podcast Archetypes, where Mindy Kaling talks about becoming a single mother by choice. We live in such a judgmental world, so I salute every woman who is brave enough to make this choice.”
Says Eliz on who is your celebrity crush: “Bernie Sanders. Check him out as a young hottie, y’all…”
(Cookie photo and recipe by Yossy Arefi/Instagram.)
[ad_2]
Source link
Computer Models Could Be Next Step in Decoding the Brain

[ad_1]
Sept. 16, 2022 – All day long, your brain cells are sending and receiving messages through electrical and chemical signals. These messages help you do things like move your muscles and use your senses – as you taste your food, feel the heat coming off a stove, or read the words on this page.
If we could better understand how those messages are sent and received, we’d gain powerful insights into the brain-body connection and shed light on what’s happening when those connections aren’t working – as with brain diseases such as Alzheimer’s and Parkinson’s.
To that end, neuroscientists at Cedars-Sinai in Los Angeles have built computer models of individual brain cells – the most complex models to date, they say. Using high-performance computing and artificial intelligence, or AI, the models, as described in the journal Cell Reports, capture the shape, timing, and speed of the electrical signals that brain cells called neurons fire.
The new research is part of a decades-long pursuit among scientists to understand the inner workings of the brain, not just cognitively but biologically, genetically, and electrically.
The most famous early researchers were Alan Lloyd Hodgkin, Andrew Fielding Huxley, and John Carew Eccles, who won the 1963 Nobel Prize in Medicine for their discoveries about nerve cell membranes.
“Today is a unique moment when detailed, single-neuron data sets are available in large quantities and for many cells,” says study author, Costas Anastassiou, PhD, a research scientist in the Department of Neurosurgery at Cedars-Sinai. “The size and speed of today’s computers allows us to explore [detailed] mechanisms at a single-cell level – for every cell.”
How Do You Model Brain Cell Activity Using a Computer?
Turns out, the electrical pulses neurons use to communicate can be replicated using computer code.
“We replicated the distinct voltage waveforms and time trajectories of these pulses using mathematical equations,” says Anastassiou. Then they built computer models using data sets from experiments in mice.
These experiments measure certain things in the cells – like their size, shape, and structure, or how they respond to changes. Each cell model combines all these elements and can help reveal how they connect.
Computer models can reconcile two critical pieces of information: the cellular makeup (building blocks of brain cells) and the patterns observed during brain activity. With the computer’s help, links between the data sets become clear. This could help pave the way to discover what actually causes the brain to change, the researchers say – a crucial step when looking at disorders.
What Can Computers Tell Us About the Human Brain?
One of the exciting potential uses of the brain cell models would be to test all kinds of theories about brain disorders that would be difficult or impossible to create through experiments in the lab. Beyond that, the work can lead to new insights about the brain: how similar or different brain cells are, what connects or makes them different, and what that means across a spectrum of properties.
Computers and mathematics are telling stories about the brain, and Anastassiou says for him, the fascination comes from the simplicity of the outcome and the richness of their impacts.
“I have always been fascinated by the question of how mathematical equations represent living, computing, biological cells – particularly so for the brain, the epicenter of what makes us human,” he says.
[ad_2]
Source link


